Use of Drotrecogin Alfa (Activated) in Bariatric Surgery Patients with Severe Sepsis Syndrome: Experience in an Urban Community Teaching Hospital

Background: Severe sepsis syndrome (SSS) and septic shock have an associated mortality ranging from 31 to 60%. Drotrecogin alfa (activated), activated protein C (APC), has been shown in a recent trial to decrease mortality from 44 to 31% in patients with SSS and a high risk of death. We present 3 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Savel, Richard H, Pulipati, Ravi C, Mangone-Cholewczynski, Connie, Lazzaro, Richard S, Macura, Jerzy M, Lehman, Herbert E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102287/
https://www.ncbi.nlm.nih.gov/pubmed/14980044
http://dx.doi.org/10.1381/096089204772787392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102287/
https://www.ncbi.nlm.nih.gov/pubmed/14980044
http://dx.doi.org/10.1381/096089204772787392

Ejemplares similares